Each year, the Drug Hunter website highlights the small molecule of the year. Deucravacitinib emerged as the most popular of the ten nominees.

Drug Hunter is a website dedicated to drug discovery. It brings together new methods, potential drugs and research in an accessible way. As a standard feature since 2020, the scientists behind the site highlight ten ‘molecules of the month’. At the end of the year, ten nominations are shortlisted and readers vote for the Molecule of the Year.

This year, deucravacitinib received the most votes from the drug discovery community.